1Medical Imaging Center, The First Affiliated Hospital of Jinan University, Guangzhou, China
2MRI Research, GE Healthcare (China), Beijing, China
3The Guangzhou Key Laboratory of Molecular and Functional Imaging for Clinical Translation, The First Affiliated Hospital of Jinan University, Guangzhou, China
4Department of Radiology and Nuclear Medicine, The Fifth Affiliated Hospital of Jinan University (Shenhe People’s Hospital), China
Presenting Author: Lingtao Zhang
Synopsis
Motivation:
Goals:
Approach:
Results:
Preview figure
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public on 13 May 2028.
To request or purchase access, contact the ISMRM Central Office at support@ismrm.org.
1. Hu X, Ye K, Bo S, et al. Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach. J Transl Med. 2024;22(1):712.
2. Ioannou M, Paraskeva E, Baxevanidou K, et al. HIF-1alpha in colorectal carcinoma: review of the literature. J BUON, 2015, 20: 680-9.
3. Lyssiotis CA, Kimmelman AC. Metabolic Interactions in the Tumor Microenvironment. Trends Cell Biol, 2017;27:863-875.
4. Huang YS, Chen JL, Chen HM, et al. Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer. BMC Cancer, 2021, 21: 348.
5. Shi X, Yang W, Ma Q, et al. Hemoglobin-mediated biomimetic synthesis of paramagnetic O(2)-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor. Theranostics, 2020, 10(25): 11607-21.